SE9602496D0 - Method and means for producing a fibrinogen binding protein and its use in biotechnology - Google Patents

Method and means for producing a fibrinogen binding protein and its use in biotechnology

Info

Publication number
SE9602496D0
SE9602496D0 SE9602496A SE9602496A SE9602496D0 SE 9602496 D0 SE9602496 D0 SE 9602496D0 SE 9602496 A SE9602496 A SE 9602496A SE 9602496 A SE9602496 A SE 9602496A SE 9602496 D0 SE9602496 D0 SE 9602496D0
Authority
SE
Sweden
Prior art keywords
protein
fibrinogen binding
producing
binding protein
biotechnology
Prior art date
Application number
SE9602496A
Other languages
English (en)
Swedish (sv)
Inventor
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan-Ingmar Flock
Martin Kjell Lindberg
Original Assignee
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan Ingmar Flock
Martin Kjell Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Guss, Martin Nilsson, Lars Frykberg, Jan Ingmar Flock, Martin Kjell Lindberg filed Critical Bengt Guss
Priority to SE9602496A priority Critical patent/SE9602496D0/xx
Publication of SE9602496D0 publication Critical patent/SE9602496D0/xx
Priority to AT97928617T priority patent/ATE316979T1/de
Priority to EP97928617A priority patent/EP0922056B1/en
Priority to DE69735207T priority patent/DE69735207T2/de
Priority to CA002294433A priority patent/CA2294433A1/en
Priority to PCT/SE1997/001091 priority patent/WO1997048727A1/en
Priority to AU32825/97A priority patent/AU3282597A/en
Priority to ES97928617T priority patent/ES2258280T3/es
Priority to JP50281998A priority patent/JP4173549B2/ja
Priority to US09/147,405 priority patent/US6733758B1/en
Priority to US10/806,288 priority patent/US7160990B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9602496A 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology SE9602496D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology
US09/147,405 US6733758B1 (en) 1996-06-20 1997-06-18 Fibrinogen binding protein originating from coagulase-negative staphylococcus
CA002294433A CA2294433A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
EP97928617A EP0922056B1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
DE69735207T DE69735207T2 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
AT97928617T ATE316979T1 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
PCT/SE1997/001091 WO1997048727A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
AU32825/97A AU3282597A (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
ES97928617T ES2258280T3 (es) 1996-06-20 1997-06-18 Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo.
JP50281998A JP4173549B2 (ja) 1996-06-20 1997-06-18 コアグラーゼ陰性ブドウ球菌に由来する、新規フィブリノーゲン結合たん白質
US10/806,288 US7160990B2 (en) 1996-06-20 2004-03-23 Antibodies to a fibrinogen binding protein of staphylococcus epidermidis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Publications (1)

Publication Number Publication Date
SE9602496D0 true SE9602496D0 (sv) 1996-06-20

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Country Status (10)

Country Link
US (2) US6733758B1 (enExample)
EP (1) EP0922056B1 (enExample)
JP (1) JP4173549B2 (enExample)
AT (1) ATE316979T1 (enExample)
AU (1) AU3282597A (enExample)
CA (1) CA2294433A1 (enExample)
DE (1) DE69735207T2 (enExample)
ES (1) ES2258280T3 (enExample)
SE (1) SE9602496D0 (enExample)
WO (1) WO1997048727A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
AU1537699A (en) * 1997-11-26 1999-06-15 Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency Extracellular matrix-binding proteins from (staphylococcus aureus)
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6635473B1 (en) * 1998-08-31 2003-10-21 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Polypeptides and polynucleotides from coagulase-negative staphylococci
CA2341177A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CA2478029A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
ES2730275T3 (es) 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
KR101541383B1 (ko) 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2007127339A2 (en) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Multi-stage microporation device
SI2445522T1 (sl) 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa
CA2768204A1 (en) 2009-07-15 2011-01-20 Aimm Therapeutics B.V. Gram-positive bacteria specific binding compounds
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
KR20230031322A (ko) 2020-06-27 2023-03-07 크레센타 바이오사이언시즈 세포 물질대사를 조정하는 화합물의 조성물 및 사용 방법
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ATE95187T1 (de) * 1988-07-15 1993-10-15 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
EP0621875B1 (en) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
ATE316979T1 (de) 2006-02-15
CA2294433A1 (en) 1997-12-24
JP2001503609A (ja) 2001-03-21
DE69735207T2 (de) 2006-11-02
JP4173549B2 (ja) 2008-10-29
US20040209326A1 (en) 2004-10-21
WO1997048727A1 (en) 1997-12-24
EP0922056B1 (en) 2006-02-01
AU3282597A (en) 1998-01-07
US7160990B2 (en) 2007-01-09
US6733758B1 (en) 2004-05-11
ES2258280T3 (es) 2006-08-16
EP0922056A1 (en) 1999-06-16
DE69735207D1 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
SE9602496D0 (sv) Method and means for producing a fibrinogen binding protein and its use in biotechnology
DE69131580D1 (de) GDF-1 und UOG1 Proteine
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
NO984415D0 (no) Peptider med antiproliferative egenskaper
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE419358T1 (de) Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
DE69728897D1 (de) Saeugetierchemokine
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
CY1110308T1 (el) Μοριο νουκλεϊνικου οξεος, το οποιο περιλαμβανει μια κωδικευσουσα για αιμοκυανινη ακολουθια νουκλεϊνικου οξεος και τουλαχιστον μια ακολουθια ιντρονιου
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
EP0887410A3 (en) DNA encoding a plasminogen activating protein
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
ATE351909T1 (de) Neue peptidfragmente zur reinigung von proteinen
SE0003573D0 (sv) Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology